BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 15866876)

  • 1. SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms.
    Qin J; Qian Y; Yao J; Grace C; Li X
    J Biol Chem; 2005 Jul; 280(26):25233-41. PubMed ID: 15866876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Toll-interleukin 1 receptor mediated signaling.
    Li X; Qin J
    J Mol Med (Berl); 2005 Apr; 83(4):258-66. PubMed ID: 15662540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway.
    Li C; Zienkiewicz J; Hawiger J
    J Biol Chem; 2005 Jul; 280(28):26152-9. PubMed ID: 15849357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
    Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
    Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B.
    Loiarro M; Sette C; Gallo G; Ciacci A; Fantò N; Mastroianni D; Carminati P; Ruggiero V
    J Biol Chem; 2005 Apr; 280(16):15809-14. PubMed ID: 15755740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
    Burns K; Janssens S; Brissoni B; Olivos N; Beyaert R; Tschopp J
    J Exp Med; 2003 Jan; 197(2):263-8. PubMed ID: 12538665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2.
    Yang RB; Mark MR; Gurney AL; Godowski PJ
    J Immunol; 1999 Jul; 163(2):639-43. PubMed ID: 10395652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.
    Martin MU; Wesche H
    Biochim Biophys Acta; 2002 Nov; 1592(3):265-80. PubMed ID: 12421671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential roles for NF-kappa B and a Toll/IL-1 receptor domain-specific signal(s) in the induction of I kappa B-zeta.
    Eto A; Muta T; Yamazaki S; Takeshige K
    Biochem Biophys Res Commun; 2003 Feb; 301(2):495-501. PubMed ID: 12565889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88.
    Dunne A; Ejdeback M; Ludidi PL; O'Neill LA; Gay NJ
    J Biol Chem; 2003 Oct; 278(42):41443-51. PubMed ID: 12888566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells.
    Medvedev AE; Lentschat A; Wahl LM; Golenbock DT; Vogel SN
    J Immunol; 2002 Nov; 169(9):5209-16. PubMed ID: 12391239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction.
    Brint EK; Fitzgerald KA; Smith P; Coyle AJ; Gutierrez-Ramos JC; Fallon PG; O'Neill LA
    J Biol Chem; 2002 Dec; 277(51):49205-11. PubMed ID: 12368275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
    Jiang Z; Mak TW; Sen G; Li X
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88.
    Janssens S; Burns K; Tschopp J; Beyaert R
    Curr Biol; 2002 Mar; 12(6):467-71. PubMed ID: 11909531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling.
    Gohda J; Matsumura T; Inoue J
    J Immunol; 2004 Sep; 173(5):2913-7. PubMed ID: 15322147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling.
    Rao N; Nguyen S; Ngo K; Fung-Leung WP
    Mol Cell Biol; 2005 Aug; 25(15):6521-32. PubMed ID: 16024789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
    Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
    Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals.
    Williams KL; Lich JD; Duncan JA; Reed W; Rallabhandi P; Moore C; Kurtz S; Coffield VM; Accavitti-Loper MA; Su L; Vogel SN; Braunstein M; Ting JP
    J Biol Chem; 2005 Dec; 280(48):39914-24. PubMed ID: 16203735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.
    Häcker H; Vabulas RM; Takeuchi O; Hoshino K; Akira S; Wagner H
    J Exp Med; 2000 Aug; 192(4):595-600. PubMed ID: 10952730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.